suppresses the immune response (39, inhibits gastric acid secretion (3), stimulates DNA synthesis (6, 12, 27, 38) accelerates wound healing (3 1, 40) ,and causes angiogenesis in the avascular corneal stroma (1 5). In accordance with these effects, EGF and its receptors are present in various tissues in the fetus and adult (1, 4, 1 1, 14, 30, 33) . Though EGF most probably has an important physiological role, this remains undefined.
Body fluids of man (20) and mouse (21) contain variable amounts of EGF. In particular, urinary concentrations are very high (2 1,4 1). Mouse urine EGF is structurally similar to human urine EGF or urogastrone (1 8). In addition to their similar amino acid sequences, both exhibit similar biological activities including inhibition of gastric acid secretion, acceleration of eyelid opening, and stimulation of cell proliferation in culture (17) .
By chromatographic analysis, mouse urine contains two immunoreactive components, a major component which co-elutes with mouse EGF standard (mol wt 6,045) and a minor component of high molecular weight, approximately 30,000 (21) . The significance of the latter material is unclear. It may represent a biosynthetic precursor of EGF. The urine of male and female mice contains similar amounts of EGF (2 l), though its concentration in the SMG is some 15-fold higher in the male (4). It is unclear which tissues contribute to urinary EGF. Limited knowledge in this area prompted the present investigation.
This paper provides evidence for the existence in neonatal mouse urine of EGF similar in molecular size to mouse standard EGF, but in concentrations much smaller than in the adult. Moreover, urinary EGF is subject to thyroid hormone modulation during the neonatal period when SMG-EGF is insensitive to thyroid hormones. In contrast, while the kidney has been suggested to synthesize EGF (18) , its EGF content appeared unresponsive to thyroid hormone.
MATERIALS AND METHODS

Animals.
For studies involving adult females, Swiss-Webster mice were purchased from Simonsen Laboratories, Gilroy, CA, 5 to 7 days prior to study. They were housed two per cage on arrival, kept under controlled temperature (20" C) and lighting (1 2-h light/ 12-h darkness) and provided with regular laboratory chow and water ad libitum.
Multiparous pregnant mice of known gestation were obtained from the same supplier 4-5 days before delivery and housed individually. Pups born within 14-16 h were pooled and distributed 8 pups/mother. The day of birth is considered day 0. For thyroid hormone response studies, pups were injected subcutaneously with T4 (0.4 pg/g body weight in 5 pl 0.001 N NaOH) daily on days 0 through 6 while control pups were injected with the same volumes of solvent. Both pups and mothers were transferred to new cages every 3 days. Cotton was added to their cages for warmth. All pups were sacrificed 24 h after the last injection. Spontaneously voided urine was collected from animals prior to sacrifice and stored at -20" C. Blood collected from the neck was allowed to clot at room temperature for 1 h; serum was separated following centrifugation and stored at -20" C. SMGs and kidneys were removed, weighed, frozen on dry ice, and stored at -20" C.
Tissues from adult female mice were removed after collecting blood from the inferior vena cava. All tissues were weighed, frozen immediately on dry ice, and stored at -20" C.
Preparation of tissue hornogenate supernatants. Both SMG and kidney tissues obtained from neonatal animals were pooled (4 or 8/homogenizing vessel) and homogenized using a glassTeflon homogenizer in 4 volumes of ice-cold 0.05 M PBS, pH 7.2, containing 0.05% Na azide. Adult tissues were individually processed using 9 volumes of the PBS. All tissue homogenates were spun at 100,000 x g for 30 min using a Beckman 40.3-type rotor. The clear supernatants were used for EGF-RIA, and protein determination (26) using bovine serum albumin as standard. Adult tissue supernatants were suitably diluted with RIA buffer containing 0.5% bovine serum albumin (RIA grade), 0.5% normal rabbit serum, and 0.05% Na azide in 0.05 M PBS. EGF-RIA was performed using a liquid phase double antibody method developed in this laboratory (22, 42) . EGF concentrations in tissues were expressed per mg protein.
EGF-RIA. Upon thawing, urine samples were centrifuged and aliquots of clear urine were diluted suitably in RIA buffer and used for EGF-RIA and urea nitrogen determinations (19) .
Parallelism in RIA between standard mouse SMG-EGF and urine was assessed using 8 to 10 dilutions in triplicate. Recovery studies were performed as described earlier (22 calculated using a computer program with log logit transformation (36) .
Serum thyroid hormone measurements. Following T4 treatment of the neonates, serum T4 and T3 concentrations were measured (7, 8) . 1251-labeled T4 and T3 were purchased from New England Nuclear Corp., Boston MA.
Gel exclusion column chromatography. To assess the molecular size of neonatal mouse urinary EGF, Sephadex G-50 fine resin columns (0.9 x 56 cm) were equilibrated and developed at 4" C with 1 M acetic acid (pH 2.4) containing M Na azide. The column was calibrated using blue dextran, NaI2'I (-15,000 cpm), and unlabeled standard SMG-EGF purified by the method of Savage and Cohen (37) . Recovery studies were also performed using Iz5I-EGF.
Aliquots of urine, suitably diluted with 1 M acetic acid, were applied to the column in 0.5-ml volume and eluted by descending flow (12 ml/h); 0.4-ml fractions were collected. The fractions were evaporated to dryness using Speed Vac (Savant Instrument Inc., New York) reconstituted in 300 p1 of assay buffer and assayed directly for EGF.
Statistical analysis. Student's t test was used for evaluation of differences between groups. The dispersions of EGF concentrations were positively skewed and the SD values increased with the mean levels. Therefore, geometric means and mean _+ SEM intervals are presented throughout.
RESULTS
Neonatal urine and the SMG-EGF standard, applied in varying amounts to the RIA, produced parallel displacement lines (Fig. I) . In the chromatogram of neonatal urinary immunoreactive EGF on Sephadex G-50 fine gel column, only one component appeared and corresponded to standard mouse SMG-EGF of 6045 mol wt (Fig. 1) . This is similar to the major component found in adult mouse urine (21) .
Urinary EGF contents are expressed both per ml urine and per mg urea nitrogen. The latter provides the best comparison between neonates and adult mice since it obviates variation in urine EGF concentration produced by variation in urine water content. The average EGF concentration was 16-fold greater and the urea concentration 3-fold greater in adult urine than in newborn urine (Fig. 2) . We also measured kidney and SMG-EGF levels to assess these organs as possible sources of urinary EGF. Kidney size relative to body size was very similar in adults and newborns, but kidney EGF levels were 2.5-fold higher in the adult (Fig. 3) . Relative SMG size was slightly larger in adults ( p = 0.003) while the adult SMG-EGF concentration exceeded the newborn value 1.5 x lO4-fold (Fig. 3) .
Effects of T4 administration in newborn. The T4-treated pups were hyperactive, and measurements of serum T4 and T3 levels suggested hyperthyroid state (Table 1) . However, their growth was not affected as indicated by body weight, nor were their urine urea concentrations. Thus, their hyperthyroidism was mild.
T4 treatment brought about a 7-fold increase in newborn urine EGF concentration (Fig. 4) whether expressed per ml urine or per mg urea nitrogen. However, even after T4 treatment, newborn urine EGF levels were less than adult values. The relative SMG weight, in contrast to kidney, was markedly increased in the T4-treated pups. Both SMG and kidney EGF concentrations remained unchanged by hormone administration.
DISCUSSION
Though EGF has been detected in saliva (2 1, 29), milk, blood (2 1, 34), bile (34) , and urine (2 1, 23), very little information is presently available regarding the relative concentrations, molecular size, origin, and physiological role of EGF in these fluids. Since body fluids provide a medium of transport and exchange between various organs, a comparative study of neonatal and adult animals may provide more information on the distribution of EGF in vivo. Urine offers an easy approach to such a study because of its high EGF content and the ease of collection.
The present data demonstrate the presence of EGF of standard molecular weight (-6,045) in neonatal mouse urine, but in concentrations much lower than in the adult. In addition, our chromatographic profile reveals the absence of a high molecular weight EGF component (-30,000) in neonatal urine in contrast to its existence in adult male urine as reported by Hirata and Orth (2 1).
We measured the EGF concentration of SMG and the kidneys as possible contributors to urine EGF. Studies in pups and adult mice indicate that the mean increase in EGF concentration during development is only 2.5-fold for the kidney in contrast to 15,000-fold for the SMG and about 16-fold for the urine. This nonparallelism of the increases during development suggests that SMG and the kidneys may not be major sources of urinary EGF. This is corroborated by our present finding of a 7-fold increase in urine EGF concentration during T4 treatment of the newborn in contrast to no response in SMG-EGF concentration (a 1.3-fold increase in total content) and a questionable response in kidney EGF. Further research is needed of the extent of SMG and kidney contributions to urine EGF levels in adult and developing animals.
Recent studies in this laboratory indicated that kidneys, in contrast to other organs, do not concentrate exogenously administered EGF, at least not during the 1st week of life (2) . This observation suggested that kidneys are not a site of EGF uptake in newborn pups. Whether kidneys synthesize EGF during a particular stage of development is not clear. The present study also documents thyroid hormonal modulation of EGF in neonatal urine at a time when SMG contains very little EGF. The increase in relative SMG weight in hormone-treated pups indicates that, although this organ is responsive to thyroid hormone from birth, its EGF concentration is hormonally insensitive during the 1st week of life.
During the perinatal stage, maternal milk is the principal source of exogenous EGF in the mouse. Further work is necessary to show whether thyroid hormones alter the absorption and metabolism of milk EGF in the neonate. Recent reports suggest that breast milk EGF content changes significantly in mice during various stages of lactation (2). Our initial attempt to correlate urine EGF changes with blood EGF was unsuccessful .001 NS NS *Newborn pups were injected with thyroxine, 0.4 pg/g body wt in 5-111 volume daily from birth to day 6 while control pups were injected with the same volume of vehicle. All pups were sacrificed on day 7. For each group, a total of 40 pups were used; blood was pooled in three samples. The results are mean + SEM.
since there were marked individual variations in serum EGF content. This rules out any alteration in relative urine EGF concentration within the same litter when the blood was collected concentration secondary to changes in urea metabolism. The from the neck as opposed to the inferior vena cava.
dose and timing of the urine EGF response to T4 (from birth to The effect of T4 on urine EGF appears to be highly specific in 6 days of life) are similar to these aspects of the T4 effect on EGF that the hormone injection did not alter urine urea nitrogen in skin (22) and ocular tissue of newborn mice (24) . These results indicate that both tissue and body fluid EGF levels are subject to hormone modulation during the perinatal stage.
A recent study (l6), based on the nucleotide sequence of mouse EGF cDNA, predicted a 128,000 mol wt protein precursor (comprising 1 168 amino acids) of standard 6045 mol wt EGF. Further support for a high molecular weight EGF protein precursor has been provided (39) by structural studies of submandibular gland messenger-RNA encoding the propro-EGF which suggested that the precursor contains at least seven peptides with sequences similar to standard EGF. In the present study, we observed a single immunoreactive EGF component corresponding to standard EGF in neonatal urine. However, this does not exclude an EGF precursor or EGF-like peptides of different molecular size in tissues or urine. The development of specific RIA systems for EGF precursors may shed more light on the origin and the hormonal reguation of EGF of standard molecular weight during early stages of development.
